Posted inComunicati
SEVER LIFE SCIENCES B.V. THROUGH ITS SUBSIDIARY NORDIC PHARMA, INC. (U.S.), TO SHARE PATIENT DATA AND PATIENT EXPERIENCE STUDY FOR LACRIFILL® CANALICULAR GEL, A NOVEL THERAPY FOR OCULAR SURFACE CONTROL, DURING AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2026
COMUNICATO STAMPA - CONTENUTO PROMOZIONALE DOYLESTOWN, Pa., Oct. 7, 2026 /PRNewswire/ -- Nordic Pharma, Inc.,…









